Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.
The icare4u program features a dedicated website, with comprehensive information about the diseases, videos with medical experts, and a social media community for patients and caregivers on Facebook and YouTube
Viralex (Inosine Pranobex) is an immunomodulatory agent with broad-spectrum antiviral properties
The inspection was triggered by Shilpa's submission of applications for four ANDA's to seek approval to use this site as an alternate testing laboratory
Aflibercept is the second biosimilar product that has entered the clinical trial phase after biosimilar Adalimumab
Viralex is an immunomodulatory agent with broad-spectrum antiviral properties. It enhances both innate & adaptive immunity and strengthens the body's defence response to viral infections
The companies plan to use the proceeds to retire debt and expand operations
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
Equity raise to finance growth and investments in the biological space
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus
Subscribe To Our Newsletter & Stay Updated
